David E. Allison
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in ⓘ
-
- Cell Adhesion Molecules Research 3
- Co-authors
- Mark X. Sliwkowski (3 shared papers)Beth Y. Karlan (2 shared papers)Michael S. Gordon (2 shared papers)W. T. Edmondson (2 shared papers)David S. Mendelson (3 shared papers)David B. Agus (2 shared papers)Leonard G. Presta (1 shared paper)Janet Clarke (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Endocrinology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Limnology and Oceanography (2 papers)International Journal of Fracture (1 paper)
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
David E. Allison
22 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 108
- Radiology, Nuclear Medicine and Imaging 857
- Oncology 825
- Reproductive Medicine 115
- Immunology 254
- Molecular Biology 648
Countries citing papers authored by David E. Allison
This map shows the geographic impact of David E. Allison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Allison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Allison more than expected).
Fields of papers citing papers by David E. Allison
This network shows the impact of papers produced by David E. Allison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Allison. The network helps show where David E. Allison may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Allison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 340 | |
| 2 | 2005 | 304 | |
| 3 | 2005 | 241 | |
| 4 | 2006 | 187 | |
| 5 | 2012 | 127 | |
| 6 | 2007 | 75 | |
| 7 | 1971 | 59 | |
| 8 | 2016 | 55 | |
| 9 | 2014 | 40 | |
| 10 | 2012 | 29 | |
| 11 | 2015 | 29 | |
| 12 | 1970 | 28 | |
| 13 | 1993 | 21 | |
| 14 | Dose-response studies of recombinant humanized monoclonal antibody 2C4 in tumor xenograft models | 2003 | 20 |
| 15 | 1993 | 17 | |
| 16 | Field evaluation of an enzyme immunoassay for detection of trichinellosis in hogs in a high volume north Carolina abattoir. | 1989 | 11 |
| 17 | 1998 | 10 | |
| 18 | 2002 | 8 | |
| 19 | 1977 | 8 | |
| 20 | 2005 | 7 |
About David E. Allison
David E. Allison is a scholar working on Immunology and Allergy, Transplantation, Radiology, Nuclear Medicine and Imaging, Oncology and Genetics, having authored 22 papers that have together received 1.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), HER2/EGFR in Cancer Research (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cell Adhesion Molecules Research (3 papers), Peptidase Inhibition and Analysis (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer Treatment and Pharmacology (2 papers) and TGF-β signaling in diseases (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (857 citations), Oncology (825 citations), Reproductive Medicine (115 citations), Immunology (254 citations) and Molecular Biology (648 citations). David E. Allison has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Mark X. Sliwkowski, Beth Y. Karlan, Michael S. Gordon, W. T. Edmondson, David S. Mendelson, David B. Agus, Leonard G. Presta, Janet Clarke, Noël Dybdal and Kelly M. Flagella. Their work appears in journals such as Journal of Clinical Oncology, Endocrinology, Cancer Chemotherapy and Pharmacology, Limnology and Oceanography and International Journal of Fracture.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.